drugset / Trial / NCT06857786
Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and tolerability of satri-cel as consolidation therapy after postoperative adjuvant therapy in patients with resected gastric or gastroesophageal junction (G/GEJ) adenocarcinoma
Timeline
- Start
- 2025-03-10
- Primary completion
- 2027-06-30
- Completion
- 2030-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Satricabtagene autoleucel | Cell therapy | 2.5e+08 cells | — |